7 reports

Its Cardiovascular and Neuromodulation Products segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chroni

  • Diabetes
  • World
  • Market Size
  • bioMerieux S.A.
  • Roche Group

This segment also offers neuromodulation devices for the management of movement disorders and chronic pain.

  • Diabetes
  • Electrophysiology Device
  • World
  • Forecast
  • Market Size

This segment also offers neuromodulation devices for the management of movement disorders and chronic pain.

  • Diabetes
  • Electrophysiology Device
  • World
  • DexCom, Inc.
  • Medtronic, Inc.

Saluda Medical Pty Ltd (Saluda Medical) offers neuromodulation technology for the management of chronic pain.

  • Diabetes
  • Electrophysiology Device
  • Medical Device
  • M&A
  • Medtronic, Inc.

Electrophysiology mapping and navigation products lie in cardiovascular and neuromodulation segment and it include products like rhythm management, heart failure related products, structural heart, vascular and neuromodulation devices.

  • Diabetes
  • Electrophysiology Device
  • Abbott Laboratories, Inc.
  • Biosense Webster, Inc.
  • Boston Scientific Corporation

Interest on notes will be paid on April ## and October ##, commencing October ##, 2017.

  • Diabetes
  • Healthcare
  • Hospital
  • Pharmaceutical
  • Medtronic, Inc.

Interest on notes will be paid on April ## and October ##, commencing October ##, 2017.

  • Diabetes
  • Healthcare
  • Hospital
  • Pharmaceutical
  • Medtronic, Inc.